Effect of Aspirin on Urinary Bladder Carcinogenesis Initiated with N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide in Rats

Samuel Monroe Cohen, R. Hasegawa, T. Sakata, S. L. Johansson

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

N-[4-(5-Nitro-2-furyl)-2-thiazoIyl]formainide (FANFT), a potent urinary bladder carcinogen, is metabolically activated in vitro by a variety of enzyme systems including aerobic cooxidation by prostaglandin H synthase which is present in the rat bladder mucosa. In a previous experiment, aspirin coadministered with FANFT for 12 weeks inhibited FANFT-induced bladder carcinogenesis and enhanced forestomach carcinogenesis. To further evaluate the effects of aspirin on FANFT carcinogenesis, male F344 rats were fed either FANFT (0.2% of the diet) for 12 weeks (Group 4), aspirin (0.5% of the diet) simultaneously with FANFT for 12 weeks (Group 2), aspirin simultaneously with FANFT for 12 weeks and then subsequently to the end of the experiment (Group 1), or FANFT only followed by aspirin (Group 3). The incidence of bladder carcinoma was significantly higher when aspirin was fed after FANFT treatment (87%) compared to FANFT followed by control diet (48%) and was higher in rats given aspirin plus FANFT followed by aspirin (73%) compared to aspirin plus FANFT followed by control diet (47%). Aspirin alone given for 13 weeks (Group 6) or throughout the experiment (68 weeks) (Group 5) did not induce bladder cancer. However, in all groups administered aspirin long-term, renal papillary necrosis and renal pelvic hyperplasia and atypia were frequently observed. Only a single forestomach tumor was observed. In the present experiment, aspirin appeared to exhibit promoting activity for bladder carcinogenesis in the rat.

Original languageEnglish (US)
Pages (from-to)372-377
Number of pages6
JournalCancer Research
Volume49
Issue number2
StatePublished - Jan 15 1989

Fingerprint

FANFT
Aspirin
Carcinogenesis
Urinary Bladder
Diet
formamide
Kidney
Inbred F344 Rats
Prostaglandin-Endoperoxide Synthases

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Effect of Aspirin on Urinary Bladder Carcinogenesis Initiated with N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide in Rats. / Cohen, Samuel Monroe; Hasegawa, R.; Sakata, T.; Johansson, S. L.

In: Cancer Research, Vol. 49, No. 2, 15.01.1989, p. 372-377.

Research output: Contribution to journalArticle

@article{744ccb4b5e5947aebabf9a0db470364c,
title = "Effect of Aspirin on Urinary Bladder Carcinogenesis Initiated with N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide in Rats",
abstract = "N-[4-(5-Nitro-2-furyl)-2-thiazoIyl]formainide (FANFT), a potent urinary bladder carcinogen, is metabolically activated in vitro by a variety of enzyme systems including aerobic cooxidation by prostaglandin H synthase which is present in the rat bladder mucosa. In a previous experiment, aspirin coadministered with FANFT for 12 weeks inhibited FANFT-induced bladder carcinogenesis and enhanced forestomach carcinogenesis. To further evaluate the effects of aspirin on FANFT carcinogenesis, male F344 rats were fed either FANFT (0.2{\%} of the diet) for 12 weeks (Group 4), aspirin (0.5{\%} of the diet) simultaneously with FANFT for 12 weeks (Group 2), aspirin simultaneously with FANFT for 12 weeks and then subsequently to the end of the experiment (Group 1), or FANFT only followed by aspirin (Group 3). The incidence of bladder carcinoma was significantly higher when aspirin was fed after FANFT treatment (87{\%}) compared to FANFT followed by control diet (48{\%}) and was higher in rats given aspirin plus FANFT followed by aspirin (73{\%}) compared to aspirin plus FANFT followed by control diet (47{\%}). Aspirin alone given for 13 weeks (Group 6) or throughout the experiment (68 weeks) (Group 5) did not induce bladder cancer. However, in all groups administered aspirin long-term, renal papillary necrosis and renal pelvic hyperplasia and atypia were frequently observed. Only a single forestomach tumor was observed. In the present experiment, aspirin appeared to exhibit promoting activity for bladder carcinogenesis in the rat.",
author = "Cohen, {Samuel Monroe} and R. Hasegawa and T. Sakata and Johansson, {S. L.}",
year = "1989",
month = "1",
day = "15",
language = "English (US)",
volume = "49",
pages = "372--377",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Effect of Aspirin on Urinary Bladder Carcinogenesis Initiated with N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide in Rats

AU - Cohen, Samuel Monroe

AU - Hasegawa, R.

AU - Sakata, T.

AU - Johansson, S. L.

PY - 1989/1/15

Y1 - 1989/1/15

N2 - N-[4-(5-Nitro-2-furyl)-2-thiazoIyl]formainide (FANFT), a potent urinary bladder carcinogen, is metabolically activated in vitro by a variety of enzyme systems including aerobic cooxidation by prostaglandin H synthase which is present in the rat bladder mucosa. In a previous experiment, aspirin coadministered with FANFT for 12 weeks inhibited FANFT-induced bladder carcinogenesis and enhanced forestomach carcinogenesis. To further evaluate the effects of aspirin on FANFT carcinogenesis, male F344 rats were fed either FANFT (0.2% of the diet) for 12 weeks (Group 4), aspirin (0.5% of the diet) simultaneously with FANFT for 12 weeks (Group 2), aspirin simultaneously with FANFT for 12 weeks and then subsequently to the end of the experiment (Group 1), or FANFT only followed by aspirin (Group 3). The incidence of bladder carcinoma was significantly higher when aspirin was fed after FANFT treatment (87%) compared to FANFT followed by control diet (48%) and was higher in rats given aspirin plus FANFT followed by aspirin (73%) compared to aspirin plus FANFT followed by control diet (47%). Aspirin alone given for 13 weeks (Group 6) or throughout the experiment (68 weeks) (Group 5) did not induce bladder cancer. However, in all groups administered aspirin long-term, renal papillary necrosis and renal pelvic hyperplasia and atypia were frequently observed. Only a single forestomach tumor was observed. In the present experiment, aspirin appeared to exhibit promoting activity for bladder carcinogenesis in the rat.

AB - N-[4-(5-Nitro-2-furyl)-2-thiazoIyl]formainide (FANFT), a potent urinary bladder carcinogen, is metabolically activated in vitro by a variety of enzyme systems including aerobic cooxidation by prostaglandin H synthase which is present in the rat bladder mucosa. In a previous experiment, aspirin coadministered with FANFT for 12 weeks inhibited FANFT-induced bladder carcinogenesis and enhanced forestomach carcinogenesis. To further evaluate the effects of aspirin on FANFT carcinogenesis, male F344 rats were fed either FANFT (0.2% of the diet) for 12 weeks (Group 4), aspirin (0.5% of the diet) simultaneously with FANFT for 12 weeks (Group 2), aspirin simultaneously with FANFT for 12 weeks and then subsequently to the end of the experiment (Group 1), or FANFT only followed by aspirin (Group 3). The incidence of bladder carcinoma was significantly higher when aspirin was fed after FANFT treatment (87%) compared to FANFT followed by control diet (48%) and was higher in rats given aspirin plus FANFT followed by aspirin (73%) compared to aspirin plus FANFT followed by control diet (47%). Aspirin alone given for 13 weeks (Group 6) or throughout the experiment (68 weeks) (Group 5) did not induce bladder cancer. However, in all groups administered aspirin long-term, renal papillary necrosis and renal pelvic hyperplasia and atypia were frequently observed. Only a single forestomach tumor was observed. In the present experiment, aspirin appeared to exhibit promoting activity for bladder carcinogenesis in the rat.

UR - http://www.scopus.com/inward/record.url?scp=0024534306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024534306&partnerID=8YFLogxK

M3 - Article

C2 - 2491954

AN - SCOPUS:0024534306

VL - 49

SP - 372

EP - 377

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 2

ER -